AMPLITUDE SURGICAL overview

Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), a leading French player on the surgical technology market for lower-limb orthopedics, announces its consolidated sales for fiscal year 2022-23. Olivier Jallabert, Amplitude Surgical’s CEO , commented: " Group sales for the 2022-23 financial year, corresponding solely to the knees and hips business, are up +14.0% at constant exchange rates on the previous year. Sales growth was driven in particular by a...

Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME savings plans), a leading French player on the surgical technology market for lower-limb orthopedics, announces the closing of the sale of the entire Novastep business, specializing in extremity surgery (feet and ankles) to Enovis Corporation. The sale will generate approximately 68 million euros for Amplitude. In the next few days, Amplitude will use part of this amount to proceed with the partial early...

Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME plans) (Paris:AMPLI), a leading French player on the surgical technology market for lower-limb orthopedics, announces its sales for the third quarter and first 9 months of its 2022-23 financial year. Olivier Jallabert, Amplitude Surgical’s CEO , said: “ In the first 9 months of our 2022-23 financial year, Amplitude Surgical posted sales growth, after application of IFRS 5 and corresponding solely to...

Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME savings plans), a leading French player on the surgical technology market for lower-limb orthopedics, announces the signing of a definitive agreement with Enovis Corporation for the sale of its whole Novastep business, specialized in clinically proven foot and ankle solutions. This transaction follows the decision of the Board of Directors on June 28, 2022 to launch a strategic review of Novastep, which...

Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME savings plans) (Paris:AMPLI), a leading French player on the surgical technology market for lower-limb orthopedics, announces its results for the first half of its 2022-23 financial year. Olivier Jallabert, Amplitude Surgical’s CEO , said: “ Amplitude Surgical’s sales for the first half of its 2022-23 financial year, excluding foot and ankle activities for which a strategic review is underway,...

Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME equity savings plans) (Paris:AMPLI), a leading French player on the surgical technology market for lower-limb orthopedics, announces its sales for the first half of its 2022-23 financial year. Olivier Jallabert, Amplitude Surgical’s CEO , said: “ In the first half of our 2022-23 financial year, Amplitude Surgical recorded a 14.2% increase in Group sales before application of IFRS 5. Knee and hip...

Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME equity savings plans) (Paris:AMPLI), a leading French player on the surgical technology market for lower-limb orthopedics, announces its sales for the first quarter of its 2022-23 financial year. Olivier Jallabert, Amplitude Surgical’s CEO , said: “ In the first quarter of our 2022-23 financial year, Amplitude Surgical recorded an increase in Group sales before application of IFRS 5 of 14.1%,...

Regulatory News: Amplitude Surgical (ISIN : FR0012789667, Mnémo : AMPLI, PEA-PME eligible) (Paris:AMPLI), (“ Amplitude ” or the “ Group ”), French leader on the global surgical technology market for lower-limb orthopedics, announces its 2022-23 financial calendar. Events Dates * 2022-23 Q1 Sales Thursday, November 24, 2022 2022-23 H1 Sales Thursday, February 23, 2023 2022-23 H1 Results Wednesday, March 22, 2023 2022-23 Q3 Sales Thursday, April 20, 2023 2022-23 Full-Year Sales Thursday,...